Standout Papers

Feasibility and efficacy of CD19-targeted CAR T cells with concurrent ibrutinib for CLL after ibrutinib failu... 2020 2026 2022 2024219
  1. Feasibility and efficacy of CD19-targeted CAR T cells with concurrent ibrutinib for CLL after ibrutinib failure (2020)
    Jordan Gauthier, Alexandre V. Hirayama et al. Blood

Immediate Impact

4 by Nobel laureates 5 from Science/Nature 63 standout
Sub-graph 1 of 23

Citing Papers

Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia
2025 Standout
Novel strategies to manage CAR-T cell toxicity
2025 Standout
1 intermediate paper

Works of Barbara S. Pender being referenced

Feasibility and efficacy of CD19-targeted CAR T cells with concurrent ibrutinib for CLL after ibrutinib failure
2020 Standout

Author Peers

Author Last Decade Papers Cites
Barbara S. Pender 362 100 115 139 19 432
Aesha Vakil 363 126 121 151 16 459
Matthew L. Ulrickson 301 76 64 149 32 381
Christine Dehner 381 84 63 142 19 496
Xinjie Xu 277 152 65 55 35 456
Marion Alcantara 249 99 71 138 24 383
Yvette Bernal 371 140 51 50 21 451
Paul Maciocia 361 128 32 114 23 486
Florence Morin 217 92 40 78 25 460
Tom Hofland 225 96 179 93 18 422
Angela Hückelhoven‐Krauss 309 127 35 32 26 374

All Works

Loading papers...

Rankless by CCL
2026